Bispecific Nanoplatforms
We aim to develop a revolutionary nanotechnology for overcoming current challenges of bi- and multispecific antibodies. Bi-and multi-specific nanoparticles can improve design, stability, pharmacokinetic profiles and safety, and can be designed to address tumor heterogeneity and immunoregulatory pathways in solid tumors. This will provide a flexible and versatile toolbox for robust and safe antitumor immune response, combining multiple therapeutic concepts for next-generation personalized cancer immunotherapy.
.